Amcure is a biopharmaceutical company developing first-in-class cancer therapeutics. The company develops peptide-based compounds for the treatment of highly metastatic forms of cancer. amcure’s most advanced development candidate, AMC303, has entered clinical development and has demonstrated in in vivo proof-of-concept studies a high efficacy against different types of epithelial cancers. 
Company Growth (employees)
Type
Private
HQ
Eggenstein Leopoldshafen, DE
Founded
2011
Size (employees)
6 (est)
Website
amcure.com
amcure was founded in 2011 and is headquartered in Eggenstein-Leopoldshafen, DE

Key People at amcure

Matthias Klaften

Matthias Klaften

CEO
Alexandra Matzke

Alexandra Matzke

CSO

amcure Office Locations

amcure has an office in Eggenstein-Leopoldshafen
Eggenstein Leopoldshafen, DE (HQ)
Eggenstein

amcure Data and Metrics

Summary Metrics

Founding Date

2011

Total Funding

$13.1 m

Latest funding size

$6.4 m

Time since last funding

5 months

Investors

amcure's latest funding round in December 2016 was reported to be $6.4 m. In total, amcure has raised $13.1 m

amcure Company Life and Culture

You may also be interested in